相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Serelaxin treatment reverses vascular dysfunction and left ventricular hypertrophy in a mouse model of Type 1 diabetes
Hooi Hooi Ng et al.
SCIENTIFIC REPORTS (2017)
Serelaxin improves cardiac and renal function in DOCA-salt hypertensive rats
Dong Wang et al.
SCIENTIFIC REPORTS (2017)
N-Acetylcysteine Attenuates the Development of Renal Fibrosis in Transgenic Mice with Dilated Cardiomyopathy
Beverly Giam et al.
SCIENTIFIC REPORTS (2017)
Effects of serelaxin in acute heart failure patients with renal impairment: results from RELAX-AHF
Licette C. Y. Liu et al.
CLINICAL RESEARCH IN CARDIOLOGY (2016)
被撤回的出版物: A role for genetic susceptibility in sporadic focal segmental glomerulosclerosis (Retracted Article. See vol 126, pg 1603, 2016)
Haiyang Yu et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Telomere dynamics during aging in polygenic left ventricular hypertrophy
Francine Z. Marques et al.
PHYSIOLOGICAL GENOMICS (2016)
N-acetylcysteine attenuates the development of cardiac fibrosis and remodeling in a mouse model of heart failure
Beverly Giam et al.
PHYSIOLOGICAL REPORTS (2016)
Principles and standards for reporting animal experiments in The Journal of Physiology and Experimental Physiology
David Grundy
JOURNAL OF PHYSIOLOGY-LONDON (2015)
Pathogenesis and treatment of the cardiorenal syndrome: Implications of L-arginine-nitric oxide pathway impairment
Niwanthi W. Rajapakse et al.
PHARMACOLOGY & THERAPEUTICS (2015)
Sequoyitol ameliorates diabetic nephropathy in diabetic rats induced with a high-fat diet and a low dose of streptozotocin
Xian-Wei Li et al.
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY (2014)
Serelaxin reduces oxidative stress and asymmetric dimethylarginine in angiotensin II-induced hypertension
Jennifer M. Sasser et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2014)
Exercise training upregulates nitric oxide synthases in the kidney of rats with chronic heart failure
Daisuke Ito et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2013)
Neutralization of Tumor Necrosis Factor-Alpha Reduces Renal Fibrosis and Hypertension in Rats with Renal Failure
Frederick J. Therrien et al.
AMERICAN JOURNAL OF NEPHROLOGY (2012)
Relaxin increases human endothelial progenitor cell NO and migration and vasculogenesis in mice
Mark S. Segal et al.
BLOOD (2012)
Relaxin improves TNF-α-induced endothelial dysfunction: the role of glucocorticoid receptor and phosphatidylinositol 3-kinase signalling
Thomas Dschietzig et al.
CARDIOVASCULAR RESEARCH (2012)
Inflammatory activation: cardiac, renal, and cardio-renal interactions in patients with the cardiorenal syndrome
Paolo C. Colombo et al.
HEART FAILURE REVIEWS (2012)
Relaxin ameliorates salt-sensitive hypertension and renal fibrosis
Takuya Yoshida et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2012)
A Purpose-Synthesised Anti-Fibrotic Agent Attenuates Experimental Kidney Diseases in the Rat
Richard E. Gilbert et al.
PLOS ONE (2012)
Mechanisms of Tubulointerstitial Fibrosis
Michael Zeisberg et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)
Cytoglobin, a novel globin, plays an antifibrotic role in the kidney
Imari Mimura et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2010)
Relaxin reverses cardiac and renal fibrosis in spontaneously hypertensive rats
ED Lekgabe et al.
HYPERTENSION (2005)
Exogenous nitric oxide modulates the systemic inflammatory response and improves kidney function after risk-situation abdominal aortic surgery
FS Lozano et al.
JOURNAL OF VASCULAR SURGERY (2005)
Delayed treatment with lithospermate B attenuates experimental diabetic renal injury
GT Lee et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2003)
Comparison between the enzymatic Vitros assay for creatinine determination and three other methods adapted on the Olympus analyzer
S Badiou et al.
JOURNAL OF CLINICAL LABORATORY ANALYSIS (2003)
β2-adrenergic receptor overexpression exacerbates development of heart failure after aortic stenosis
XJ Du et al.
CIRCULATION (2000)
分享论文
